Camp Lejeune Update, July 2026

The Camp Lejeune water-contamination litigation is one of the largest tort undertakings in American history, and it is unlike almost any other mass tort because the defendant is the federal government. At mid-2026, it presents a split screen. On one side, the Justice Department is writing settlement checks at an accelerating pace through a voluntary administrative program. On the other, the actual courtroom litigation has stalled over two threshold questions, one about who decides these cases and one about how causation must be proven. Here is where each piece stands.

The settlement machine: the Elective Option

The fastest path to compensation is not a trial but the Elective Option, a voluntary framework the Justice Department and the Department of the Navy created in 2023 to resolve claims without litigation. Payments accelerated sharply after the Justice Department made the program a priority. In a March 10, 2026 announcement, the DOJ Civil Division said it had approved 649 Elective Option offers worth $175 million in just three weeks, bringing the total approved since the program launched in 2023 to 2,531 offers worth roughly $708 million, with more than $421 million actually paid out since January 2025. Local coverage from WECT in Wilmington and WITN confirmed the figures, and Associate Attorney General Stanley Woodward framed the surge as a reprioritization after years of delay. Individual payouts under the program range from $100,000 to $550,000, as the Washington Times reported, scaled to the claimant's illness and length of exposure, and are available regardless of which part of the base a person lived or worked on. Settlement offers and payments have continued to climb past those March totals in subsequent court status filings.

The catch is scale. More than 400,000 administrative claims were filed with the Navy before the window closed, which means the money disbursed so far, however large in absolute terms, has resolved only a small fraction of the total. For every claimant who has been paid, thousands are still waiting, and federal workforce reductions have added to the processing backlog.

The courtroom stall, part one: no juries

For claimants who reject the Elective Option and litigate, all cases are consolidated in the U.S. District Court for the Eastern District of North Carolina, currently before four federal judges. The most consequential ruling in the entire litigation was handed down early and still shapes everything. In February 2024, a panel of those judges ruled that Camp Lejeune plaintiffs are not entitled to jury trials, as Bloomberg Law reported. The panel reasoned that Congress had not clearly and unequivocally granted a jury-trial right against the United States when it passed the Camp Lejeune Justice Act, so a judge, rather than a jury, will decide both liability and damages in every case.

Plaintiffs have fought that decision hard, arguing that the statute's text preserving "the right of any party to a trial by jury" means exactly what it says, and they carried the challenge up the appellate chain to the Supreme Court. The ruling has nonetheless held, and the practical stakes are significant. Bench trials tend to be faster, but plaintiffs' lawyers widely believe judges award less than sympathetic juries would, which depresses both trial values and the settlement offers that trials are supposed to drive. As one Camp Lejeune veteran and former trial lawyer argued in an op-ed for Roll Call, the order effectively handed the judges a role Congress had assigned to North Carolina jurors.

The courtroom stall, part two: proving causation

The second bottleneck is scientific. The court organized the thousands of lawsuits into tracks by illness, and Track 1 covers the five conditions with the strongest evidence linking them to the base's contaminated water: bladder cancer, kidney cancer, leukemia, non-Hodgkin lymphoma, and Parkinson's disease. Roughly two dozen Track 1 cases were selected as the first to be tried. Before any of them can proceed, though, the court has to resolve how causation gets proven, and that fight has consumed the first half of 2026 through hearings on expert testimony and a wave of motions to exclude each side's scientific witnesses. The Justice Department has pressed the court to decide its causation arguments first and has challenged the plaintiffs' experts, while plaintiffs argue the Camp Lejeune Justice Act deliberately set a claimant-friendly standard, requiring only that a causal link be "at least as likely as not." As of mid-year, no Track 1 bellwether trial date had been firmly set, and the government was reported to be seeking to position the remaining bellwether cases for trial by the end of 2026.

The legislative front: a fix aimed at both problems

Because both bottlenecks stem from how courts have read the statute, some in Congress want to rewrite it. The Ensuring Justice for Camp Lejeune Victims Act, introduced in the current Congress, would target both issues at once. According to a fact sheet from Senator Thom Tillis's office, the bill would restore the jury-trial right that the Eastern District of North Carolina found lacking, and would clarify that victims need only show general causation rather than prove exactly which contaminated water source they used on base decades ago, evidence the sponsors note is often impossible to obtain after 40 to 70 years. Whether the bill advances is uncertain, but its existence underscores that the litigation's central disputes are as much about statutory interpretation as about science.

The background, briefly

The underlying facts are not seriously contested. From the 1950s through the 1980s, drinking water at Marine Corps Base Camp Lejeune was contaminated with industrial solvents including trichloroethylene, tetrachloroethylene, benzene, and vinyl chloride. The Camp Lejeune Justice Act, enacted in August 2022 as part of the PACT Act, gave anyone who lived or worked at the base for at least 30 days between 1953 and 1987 a two-year window, which closed on August 10, 2024, to sue the federal government for related illnesses. The Agency for Toxic Substances and Disease Registry has continued to publish research linking base exposure to elevated cancer risk, work that feeds directly into the causation fights now playing out in court.

What to watch in the second half of 2026

Three things will define the rest of the year. First, watch whether the court finally sets a Track 1 bellwether trial date, and whether the parties instead reach a global settlement framework, which has been discussed with the court's help but never finalized. Second, watch the causation rulings, because the standards the judges set for the first five conditions will effectively price thousands of other claims. Third, watch Congress, where the jury-trial and general-causation fixes would reshape the litigation's value overnight if they passed. For now, the defining feature of Camp Lejeune in 2026 is the gap between a settlement program moving faster than ever and a courtroom process that has yet to hold its first trial.

‍